100 related articles for article (PubMed ID: 8584558)
1. Self assembling nanostructures for sustained ophthalmic drug delivery.
Khopade AJ; Jain NK
Pharmazie; 1995 Dec; 50(12):812-4. PubMed ID: 8584558
[TBL] [Abstract][Full Text] [Related]
2. Development of reconstitutable suspensions containing diclofenac sodium-loaded microspheres for pediatric delivery.
Oz UC; Devrim B; Bozkır A; Canefe K
J Microencapsul; 2015; 32(4):317-28. PubMed ID: 26154114
[TBL] [Abstract][Full Text] [Related]
3. Diclofenac-loaded Eudragit S100 nanosuspension for ophthalmic delivery.
Ahuja M; Dhake AS; Sharma SK; Majumdar DK
J Microencapsul; 2011; 28(1):37-45. PubMed ID: 21171815
[TBL] [Abstract][Full Text] [Related]
4. Eudragit-coated aceclofenac-loaded pectin microspheres in chronopharmacological treatment of rheumatoid arthritis.
Ramasamy T; Ruttala HB; Shanmugam S; Umadevi SK
Drug Deliv; 2013 Feb; 20(2):65-77. PubMed ID: 23537465
[TBL] [Abstract][Full Text] [Related]
5. Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen.
Pignatello R; Bucolo C; Ferrara P; Maltese A; Puleo A; Puglisi G
Eur J Pharm Sci; 2002 Jul; 16(1-2):53-61. PubMed ID: 12113891
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamics of diclofenac from novel Eudragit entrapped microspheres.
Momoh MA; Kenechukwu FC; Adedokun MO; Odo CE; Attama AA
Drug Deliv; 2014 May; 21(3):193-203. PubMed ID: 24171400
[TBL] [Abstract][Full Text] [Related]
7. Eudragit matrices for sustained release of ketorolac tromethamine: formulation and kinetics of release.
Ruckmani K; Muneera MS; Vijaya R
Boll Chim Farm; 2000; 139(5):205-8. PubMed ID: 11213438
[TBL] [Abstract][Full Text] [Related]
8. Electrospun diclofenac sodium loaded Eudragit® L 100-55 nanofibers for colon-targeted drug delivery.
Shen X; Yu D; Zhu L; Branford-White C; White K; Chatterton NP
Int J Pharm; 2011 Apr; 408(1-2):200-7. PubMed ID: 21291969
[TBL] [Abstract][Full Text] [Related]
9. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres.
Rawat M; Saraf S; Saraf S
AAPS PharmSciTech; 2007 Dec; 8(4):E116. PubMed ID: 18181537
[TBL] [Abstract][Full Text] [Related]
10. The physical and chemical stability of suspensions of sustained-release diclofenac microspheres.
Lewis L; Boni RL; Adeyeye CM
J Microencapsul; 1998; 15(5):555-67. PubMed ID: 9743912
[TBL] [Abstract][Full Text] [Related]
11. Effect of emulsifier blend on the characteristics of sustained release diclofenac microspheres.
Lewis L; Boni R; Adeyeye CM
J Microencapsul; 1998; 15(3):283-98. PubMed ID: 9608393
[TBL] [Abstract][Full Text] [Related]
12. Formulation and evaluation of chitosan microspheres of aceclofenac for colon-targeted drug delivery.
Umadevi SK; Thiruganesh R; Suresh S; Reddy KB
Biopharm Drug Dispos; 2010 Oct; 31(7):407-27. PubMed ID: 20848388
[TBL] [Abstract][Full Text] [Related]
13. Formulation optimization of double emulsification method for preparation of enzyme-loaded Eudragit S100 microspheres.
Rawat M; Saraf S
J Microencapsul; 2009 Jun; 26(4):306-14. PubMed ID: 18686142
[TBL] [Abstract][Full Text] [Related]
14. In-vitro studies of enteric coated diclofenac sodium-carboxymethylcellulose microspheres.
Arica B; Arica MY; Kaş HS; Hincal AA; Hasirci V
J Microencapsul; 1996; 13(6):689-99. PubMed ID: 8933354
[TBL] [Abstract][Full Text] [Related]
15. Formulation and evaluation of reconstitutable suspensions containing ibuprofen-loaded Eudragit microspheres.
Devrim B; Bozkir A; Canefe K
Acta Pol Pharm; 2011; 68(4):593-9. PubMed ID: 21796942
[TBL] [Abstract][Full Text] [Related]
16. Ultrasonically controlled release and targeted delivery of diclofenac sodium via gelatin magnetic microspheres.
Saravanan M; Bhaskar K; Maharajan G; Pillai KS
Int J Pharm; 2004 Sep; 283(1-2):71-82. PubMed ID: 15363503
[TBL] [Abstract][Full Text] [Related]
17. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
Katara R; Majumdar DK
Colloids Surf B Biointerfaces; 2013 Mar; 103():455-62. PubMed ID: 23261566
[TBL] [Abstract][Full Text] [Related]
18. Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis.
Adibkia K; Siahi Shadbad MR; Nokhodchi A; Javadzedeh A; Barzegar-Jalali M; Barar J; Mohammadi G; Omidi Y
J Drug Target; 2007 Jul; 15(6):407-16. PubMed ID: 17613659
[TBL] [Abstract][Full Text] [Related]
19. Development of gelatin microspheres loaded with diclofenac sodium for intra-articular administration.
Saravanan M; Bhaskar K; Maharajan G; Pillai KS
J Drug Target; 2011 Feb; 19(2):96-103. PubMed ID: 20380621
[TBL] [Abstract][Full Text] [Related]
20. Liposomal diclofenac eye drop formulations targeting the retina: formulation stability improvement using surface modification of liposomes.
Fujisawa T; Miyai H; Hironaka K; Tsukamoto T; Tahara K; Tozuka Y; Ito M; Takeuchi H
Int J Pharm; 2012 Oct; 436(1-2):564-7. PubMed ID: 22828072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
